Home From Drew Altman

From Drew Altman

Drew Altman is president and chief executive officer of KFF, a position he has held for more than 30 years since founding the modern-day KFF organization in the 1990s. He is a leading expert on national health policy issues and an innovator in health journalism and the nonprofit field.

View full bio | Read Dr. Altman's Beyond the Data columns

Photo of Drew Altman

President’s Message

“KFF is an independent source of health policy research, polling, and journalism. We have four major program areas: KFF Policy; KFF Polling; KFF Health News (formerly Kaiser Health News); and KFF Social Impact Media, which conducts specialized public health information campaigns. Learn more about the organization. 

What’s unique about KFF, however, can’t be found in any description of our programs because we’re more than a sum of our parts. KFF is a one-of-a-kind information organization. Not a policy research organization. Not a polling organization. And not a news organization. But rather, a unique combination of all three. That’s the vision behind KFF, and it's this combination that allows us to leverage our combined expertise and assets to play our national role on health policy.” Read more

Beyond the Data

In his “Beyond the Data” columns, Drew Altman discusses what the data, polls, and journalism produced by KFF mean for policy and for people.

A Note on How the War in Iran May Affect Health Care in the Midterms

In a new column, Dr. Drew Altman, KFF’s President and CEO, discusses the impact of the war in Iran and rising gas prices on voter concerns about health care costs. He writes: “Recently, we saw health care costs rise to the top of the public’s list of economic worries, ahead of food, housing, utility costs and the cost of gas….Expect gas prices to rise and health care costs to fall on the list of affordability worries while the war in Iran lasts, but then to return to the top or near the top when President Trump decides to declare the major hostilities over, the Strait of Hormuz is open, and gas prices come down….health care costs have staying power as one of the top voter concerns.”

View All Beyond the Data Columns

View the Latest: From Drew Altman

Filter

List Grid

281 - 290 of 336 Results

  • Poll: Most Americans Positive About Ebola Response

    From Drew Altman

    In this column for The Wall Street Journal’s Think Tank, Drew Altman looks at public confidence in the Centers for Disease Control and Prevention (CDC) amid the response to Ebola in the U.S. based on two Foundation polls taken over the past two weeks.

  • Shifting Views on Same-Sex Marriage, Marijuana and End-of-Life Issues

    From Drew Altman

    In this column for The Wall Street Journal’s Think Tank, Drew Altman examines three areas of American life where public attitudes have been steadily changing – same sex marriage, marijuana, and end of life issues – and discusses the implications for policy and law.

  • Challenges for the Next Obamacare Open Enrollment

    From Drew Altman

    In this column for The Wall Street Journal’s Think Tank, Drew Altman pinpoints the Affordable Care Act’s five biggest challenges heading into the second open enrollment period.

  • Low-Wage Workers Feel the Pinch on Health Insurance

    From Drew Altman

    In this column for The Wall Street Journal’s Think Tank, Drew Altman explores how low-wage firms and their workers are faring in the employer-based health insurance market and how the Affordable Care Act may influence future trends.

  • Calling in the Military to Fight Ebola

    From Drew Altman

    In this column for The Wall Street Journal’s Think Tank, Drew Altman discusses the President’s commitment of troops to combat the Ebola outbreak and explains the Department of Defense’s widespread role in global health activities.

  • In Employer Health Insurance Costs, Stability Is the New Normal

    From Drew Altman

    In his latest column for The Wall Street Journal’s Think Tank, Drew Altman looks at the sharply slower growth in premiums for employer health benefits and what it might mean for the future of employer-sponsored coverage.